These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells. Hirano S; Udagawa O Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170 [TBL] [Abstract][Full Text] [Related]
5. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells. Percherancier Y; Germain-Desprez D; Galisson F; Mascle XH; Dianoux L; Estephan P; Chelbi-Alix MK; Aubry M J Biol Chem; 2009 Jun; 284(24):16595-16608. PubMed ID: 19380586 [TBL] [Abstract][Full Text] [Related]
6. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence. Ivanschitz L; Takahashi Y; Jollivet F; Ayrault O; Le Bras M; de Thé H Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14278-83. PubMed ID: 26578773 [TBL] [Abstract][Full Text] [Related]
7. Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9. McManus FP; Bourdeau V; Acevedo M; Lopes-Paciencia S; Mignacca L; Lamoliatte F; Rojas Pino JW; Ferbeyre G; Thibault P Sci Rep; 2018 May; 8(1):7754. PubMed ID: 29773808 [TBL] [Abstract][Full Text] [Related]
8. RING tetramerization is required for nuclear body biogenesis and PML sumoylation. Wang P; Benhenda S; Wu H; Lallemand-Breitenbach V; Zhen T; Jollivet F; Peres L; Li Y; Chen SJ; Chen Z; de Thé H; Meng G Nat Commun; 2018 Mar; 9(1):1277. PubMed ID: 29599493 [TBL] [Abstract][Full Text] [Related]
9. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification. Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951 [TBL] [Abstract][Full Text] [Related]
10. PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. Jeanne M; Lallemand-Breitenbach V; Ferhi O; Koken M; Le Bras M; Duffort S; Peres L; Berthier C; Soilihi H; Raught B; de Thé H Cancer Cell; 2010 Jul; 18(1):88-98. PubMed ID: 20609355 [TBL] [Abstract][Full Text] [Related]
11. A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Van Damme E; Laukens K; Dang TH; Van Ostade X Int J Biol Sci; 2010 Jan; 6(1):51-67. PubMed ID: 20087442 [TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus induces NRF2 degradation through a promyelocytic leukemia protein - ring finger protein 4 dependent pathway. Komaravelli N; Ansar M; Garofalo RP; Casola A Free Radic Biol Med; 2017 Dec; 113():494-504. PubMed ID: 29107745 [TBL] [Abstract][Full Text] [Related]
13. SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome. Cao X; Clavijo C; Li X; Lin HH; Chen Y; Shih HM; Ann DK Mol Cancer Ther; 2008 Apr; 7(4):923-34. PubMed ID: 18413806 [TBL] [Abstract][Full Text] [Related]
14. Sumoylation of the Tumor Suppressor Promyelocytic Leukemia Protein Regulates Arsenic Trioxide-Induced Collagen Synthesis in Osteoblasts. Xu WX; Liu SZ; Wu D; Qiao GF; Yan J Cell Physiol Biochem; 2015; 37(4):1581-91. PubMed ID: 26517826 [TBL] [Abstract][Full Text] [Related]
15. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies. Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601 [TBL] [Abstract][Full Text] [Related]
16. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1. Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310 [TBL] [Abstract][Full Text] [Related]
18. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies. Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858 [TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation. Gao C; Ho CC; Reineke E; Lam M; Cheng X; Stanya KJ; Liu Y; Chakraborty S; Shih HM; Kao HY Mol Cell Biol; 2008 Sep; 28(18):5658-67. PubMed ID: 18625722 [TBL] [Abstract][Full Text] [Related]
20. PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation. Sahin U; de Thé H; Lallemand-Breitenbach V Nucleus; 2014; 5(6):499-507. PubMed ID: 25482067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]